Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms.
Saved in:
| Title: | Somatic co-alteration signatures are prognostic in high-grade TP53-mutated myeloid neoplasms. |
|---|---|
| Authors: | Symes EO; Pathology (Hematopathology & Genomic Pathology), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Wang P; Pathology (Hematopathology & Genomic Pathology), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Sojitra P; Pathology, Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA., Menon MP; Pathology (Hematopathology), University of Utah School of Medicine, Salt Lake City, Utah, USA., Patel AA; Pathology (Hematopathology & Genomic Pathology), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Hasan F; Hematology and Stem Cell Transplant (Hematology and Stem Cell Transplant), Sanjay Gandhi Post Graduation Institute of Medical Education & Research, Lucknow, Uttar Pradesh, India., Ghosh S; Pathology (Hematopathology), Henry Ford Health System, Detroit, Michigan, USA., Roloff GW; Pathology (Hematopathology & Genomic Pathology), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA., Zhou Q; Laboratory Medicine and Pathobiology (Hematopathology Transfusion Medicine), Laboratory Medicine Program (Laboratory Hematology), University of Toronto, Toronto, Canada., Findley A; Medicine (Internal Medicine & Hematology-Oncology), Mayo Clinic, Jacksonville, Florida, USA., Badar T; Medicine (Internal Medicine & Hematology-Oncology), Mayo Clinic, Jacksonville, Florida, USA., Zhang J; Pathology (Hematopathology), UCHealth University of Colorado Hospital, Anschutz Medical Campus, Aurora, Colorado, USA., Tariq H; Pathology (Hematopathology), Northwestern Memorial Hospital, Chicago, Illinois, USA., Chang H; Laboratory Medicine and Pathobiology (Hematopathology Transfusion Medicine), Laboratory Medicine Program (Laboratory Hematology), University of Toronto, Toronto, Canada., Bell RC; Pathology (Division of Genomic Pathology & Hematopathology), University of Michigan, Ann Arbor, Michigan, USA., Perry AM; Pathology (Division of Genomic Pathology & Hematopathology), University of Michigan, Ann Arbor, Michigan, USA., Venkataraman G; Pathology (Hematopathology & Genomic Pathology), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA. |
| Source: | British journal of haematology [Br J Haematol] 2025 Apr; Vol. 206 (4), pp. 1103-1108. Date of Electronic Publication: 2024 Nov 17. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
